Inhibikase Therapeutics Inc (IKT) stock is on a roll, skyrocketing by 31.1% to $1.56 during Wednesday’s trading session. The excitement stems from the company’s announcement of a substantial $110 million private placement financing. This significant injection of capital will fuel Inhibikase’s ambitious plans, particularly supporting a Phase 2b trial for pulmonary arterial hypertension (PAH), a serious lung condition. The funding will also cover general corporate needs, ensuring the company’s continued growth and development.
The deal, led by Soleus Capital and joined by investors like Sands Capital and Blackstone, involves the sale of common stock, pre-funded warrants, and accompanying Series A-1 and B-1 warrants. Notably, this transaction will see two board members step down, while four new directors, including Roberto Bellini and Amit Munshi, will take their place. Bellini will assume the role of independent chair. The placement is scheduled to finalize on October 21st, with Jefferies acting as the lead placement agent.
For investors interested in participating in the Inhibikase Therapeutics market, either by purchasing shares or exploring alternative strategies, there are several avenues. Buying shares is typically done through a brokerage account. These platforms often allow for the purchase of ‘fractional shares’, enabling investors to own portions of stock without having to buy an entire share, especially for high-priced companies like Berkshire Hathaway or Amazon.com. For example, with Inhibikase Therapeutics currently trading at $1.59, an investment of $100 would secure approximately 62.89 shares.
If your goal is to take a contrarian stance on Inhibikase Therapeutics, the process is more involved. It necessitates access to an options trading platform or a broker who facilitates ‘short selling’. This involves borrowing shares to sell them, hoping to buy them back at a lower price later and pocket the difference. Alternatively, options trading allows you to profit from a decline in share price by purchasing put options or selling call options at a strike price above the current trading price.
It’s important to remember that investing in the stock market carries inherent risks, and investors should conduct thorough research and seek advice from a qualified financial professional before making any investment decisions.
